Natrix raises $19 million for commercialization

Guest Contributor
September 19, 2008

Burlington ON-based Natrix Separations Inc has closed a $19-million, series B financing to support commercialization of its separation products and complete construction of its ISO9001-compliant manufacturing facility. DE Shaw Venture Capital, Cupertino CA, is the lead investors with participation by BDC Venture Capital and Canadian Medical Discovery Funds (now part of Jovian Capital Corp). The privately held company has developed its patented Adsept technology which can be used to capture specific target molecules from a broad range of feed streams. Its membrane-based chromatography applications are used to purify therapeutic drugs, produce nutraceuticals from commodity food products and remove heavy metals from drinking water. It is targeting the life science, bioprocessing , nutraceutical, food, beverage and potable water/wastewater markets….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.